9999999997-11-016937.txt : 20111129 9999999997-11-016937.hdr.sgml : 20111129 20111129104352 ACCESSION NUMBER: 9999999997-11-016937 CONFORMED SUBMISSION TYPE: CT ORDER PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20111129 DATE AS OF CHANGE: 20111129 20111129 20111129 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ELITE PHARMACEUTICALS INC /DE/ CENTRAL INDEX KEY: 0001053369 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 223542636 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: CT ORDER SEC ACT: 1934 Act SEC FILE NUMBER: 001-15697 FILM NUMBER: 111229966 BUSINESS ADDRESS: STREET 1: 165 LUDLOW AVENUE CITY: NORTHVALE STATE: NJ ZIP: 07647 BUSINESS PHONE: 2017502646 MAIL ADDRESS: STREET 1: 165 LUDLOW AVENUE CITY: NORTHVALE STATE: NJ ZIP: 07647 CT ORDER 1 filename1.pdf begin 644 filename1.pdf M)5!$1BTQ+C4-)>+CS],-"C0R(#`@;V)J#3P\+TQI;F5AF4@-34O5'EP92]84F5F+U=;,2`R(#%=/CYS=')E86T-"FC>8F)D$&!@ M8F#R!!(,4X`$XPT@P1($)-@W`(E/:QF8&!EV@F09&-&)_XPS_P`$&`#5^P?C M#0IE;F1S=')E86T-96YD;V)J#7-T87)T>')E9@T*,`T*)25%3T8-"B`@("`@ M("`-"C4T(#`@;V)J#3P\+T,@-CDO1FEL=&5R+T9L871E1&5C;V1E+TD@.3$O M3&5N9W1H(#8S+U,@,S@^/G-TYJW99^1YUM]DN MIZAQ"I1_G5],JNWJRP+U\[;.V^6&WE;U+MNBZ+[+R#!&;]IL6RROR_4V)XS. MVWSWC7"9T,7+4XZVD')=/+553;_WE2AMKJYT^N?\-Z+;K(OV<]09":SI__M%".HOZ.<>\0G(N\JK=-`_& M6/(O`:,AI21:N]%@#,'A"JT3"F<`2C0`I6'!`5;0>Z>W$.(8-L#)4\F($<(- MF<'5[Q/.0Y+2IF@+>]"E2G6VH[*48)>$"R/@?C>$)ZG1ED6!S(5(IZZ9MJ7!/4,#&= MO/,W>H".+FF,<(,X$A&PD`C!Z<",0[)^1,:`\0DW>0!@`TT:`Z8@1IB$0W%4 MNC@9)^ILN@USZ6)XP-RF@N^]I_@-^#>!.?1O"G0V>E_>#GR1;CD/ MND#+O5_,MBI)`Y$@R_:,&)@Q(I_X30G_A@_]3EQ><4_&;*MXTVT+U2+:):I>4^U_+77*NB*QH# M"O5_WAB^6(]C_MC^Y'A\3WF'Z!0`W_YCJCT&3[7'X:CVMP`#`/OX>R,-"F5N M9'-T7T%@7ZC!8D3JS2J* M`JZ=;!D6KTM48(`W#([M+!ILV8WEIOWWNSN*U&OD#6N!J#)U/-[+<\\=WZ<7 MEQ_8V[>7M].;&?/8NW?O9U-V<3F]]]CJ"`OLN,HO+M/48Y*ECQ=2P1J\*Y9X M+/;&(HE8NKO@S$G_OKBZQ:V5.FG4R3%SI9`A2]>OB"HCZAG)V2N2OI44GN>S M=,7<\NV%N;Y(DNJH!?_HA'P.?S>.XNG5#-[8O>-*GD[@-;VZ=_Y(?X(C08F' M^V.1C/'M-2L#=R M'P]$-11)6+>2/+V;463N&`;I;@()]?B\BBW%CM&JCMW\VDGT)[VQ)COYF6), M"W?P489\0C\PU$:X&5<5H$\#[H^'4`*[_09"Y\89.I:RK_/^+^&CH=.%S61* MXHPB@`%@TG$53_#AXR/H^A7*(;\2ZY?O"16>2ZNT;))^_YJ(K!=S8(LY0GN@ MGF")V(;>E`I%,&9A&`H5(.DLP-.`;[/"D8J0RCXX8_X$+TO$+*`XYLN5HU%\ M@H(GP6R%SR5(;H\C!,H-O.;P%25%*R92BB!20T&1EKDJ:O3!@3"0PAL/<*/E M,3=LD=:U(R7/,$5;?)!G5)V"D7E*WA[`_8$'7@[%K4EB\O MS#>^7F&9;K%",WP4^-@`0%U$J$L0A3ZTP^7E:G/"I<)*KY:T\X@%/&K%"EIN M)R72-R&G-@C5&1D[;G+`D`_@;@%;*!-QP72F2ZIR+5B8LSHTDO MA7Q'FS)S",L*A@J^($SP]"U&WYR*_S/<_5QJV+'BJ?P&;<#7VW`EPX1E!::/ MH<\%2C,\BUT#VUF#=M`3%/=:&?65")LDT(F55\O/KY@9"L_66MG2Z(+*<:WM M8>8;[%6-'\C;+B(.HZ>A`8D%!H#Y@];,$$+:@;`;:'FE=*L)@T3/-:YQI]*M ML^^=F%!,T$+SU@Q]0<,0P[ARL%"T0CF!L(Y^!#]^EF6L,!)F4BB+#T+@>_SK MJWA%CO&Q_5'^/Z!.S#UFN806<`J""+^?"+&K$J;;(U+VB#*%IL-X'`(`"70M M9I8XX=>)HH?T%IJZ-*\5;0WUS/2Z02#."*QG"Z0-+!6A?;6:_73",)>T@\+* MI.X1HI49*J'4,)M)ANRTSZW(VL(OKS)F%6MIPNG.*,3LXW)+)3V\GVCY9B754/V`T.^[FU M<.#@B:-9G!9'<)/X"`OB'K,N8`8`-0*F,_4[!PT/OSOPI->`7D<=6V=.J?HS M/2D/YBAM[11[*!ETH&?'(G2W%E)2:P8^]D0_JQ13U(IZOG95:]"E3.&!HE_P M?$^2VN@].YP>FIUL2ZGZZD"%LG5E_\KD?\6L)A5HB:..V'#6Q([\X/CQBJ!]T2(?"(MOI#R3!1AXK`7CQE5_6I#XS:. M%A#8YVX$ZQJY+V'B\&2H)\TX:IHK&^:[W:%B<"!1LLI&>V-/)=AH5,-;`[1( MOGH@W%$;Q;^R9;;O#C(VND9,SUA$-,@)TI#"MR?FE>E&(V!2W$`ZJ5/G#9XU MLPY='?&N!_;6>A4Q7WD=`(T$B&6=U=?4TD\:-62:(5]BZS(:+RP6T;A,T!L= M=)4,)DS9A,4BB<]6C]^IGHY(<%XD_.\U>.['T)7U%EE'WS_U*+>A6RB[Q\%P ML]1WU3:D(A$-1RZRD5,!R@[5R;?VB"RO>!3,UQY-<43:X_H)'SD^B'/!X[9[ M05P_#:Y&PY5=7374>9AT+QHD_"/``%16.%,-"F5N9'-TY!@9$1FEP'Z>@8V! MF0$,$I.+"QP#`GQ`[+S\O%0&#/#M&@,CB+ZL"S(+4QXO8$TN*"H!T@>`V"@E MM3@92'\!XLSRD@*@.&,"D"V2E`UF@]2)9(<$.0/9'4`V7TEJ!4B,P3F_H+(H M,SVC1,'0TM)2P3$E/RE5(;BRN"0UMUC!,R\YOZ@@ORBQ)#4%J!9J!PCPNQ`P8A0[CQ!#@.32HC(HDY')F($!(,`` M2<8X+PT*96YDW)+!;MLP#(9?A6\@BY1L&2@"=-T*#,6R(,E.10]>*J3& M6MMP':!]^_TVLVX[C+WODA\2F4_T)Y544$5)*)$4B6H2KL@7%%G(>ZKF%5,5 M$4)50@1*'A$I!41)J4)45!<(``114UU6Q`75-<*#!PPS,B::P46JB0,.0`]' M9/3$)3(Q+2?B,$[($(AK9!4Q'D8H2A+P!*<(>%)B;/"DQN#@!30)>*'T)."% MFFD>:/X:`2_&0`)>3)$N+MP-/KV@K=LT8^ZF_9@S-/R]L^V_6/^ MT@Q0-'?L7X?L=M-X.BQMV[Z?5JL9>0MK:)BM+2$:02-JE!J51M)8P+.U)93" M2F&EL%)8*:P45@HKA94B2A&EB%)$*:(448HH190B2I&%>N'IIQ4]/@?SV1^Y/TWEY^OY\ M&-OA;3GD\<^-/2[R0__B+C':M^X^CV^DU>I_NK/E61>XN?/3/E((YSO$>6;FMC.60B/SX*/'@Z>&UP;65T82!X;6QN#IX;7!T:STB061O8F4@6$U0($-O&UP.DUE M=&%D871A1&%T93XR,#$Q+3$Q+3(Y5#$P.C0Q.C0T+3`U.C`P/"]X;7`Z365T M861A=&%$871E/@H@("`@("`@("`\>&UP.D-R96%T;W)4;V]L/D%C&UP34TZ26YS=&%N M8V5)1#YU=6ED.CEA,#$W-&(U+60T8C$M-#&UP34TZ26YS=&%N8V5)1#X*("`@("`@("`@/'AM<$U-.G-U8FIE8W0^ M"B`@("`@("`@("`@(#QR9&8Z4V5Q/@H@("`@("`@("`@("`@("`\7=O#I3;W5R8V5-;V1I9FEE9#X*("`@("`@("`@/'!D9G@Z0V]M<&%N M>3Y396-U&AA;F=E($-O;6UI3X*("`@("`@("`@/'!D9G@Z0V]M;65N=',^5F5RD?^/V7SJ]PS^>)0G)XZ'(SP%#JVW(M4?CA088>B"<>`_J]G+J8[`4KW MCBY+UW/('ZBJ]?HJP`"$8%A)#0IE;F1S=')E86T-96YD;V)J#34@,"!O8FH- M/#PO1&5C;V1E4&%R;7,\/"]#;VQU;6YS(#0O4')E9&EC=&]R(#$R/CXO1FEL M=&5R+T9L871E1&5C;V1E+TE$6SPT,#(V-C$Q0D8W,T4V,#0R0D0R041",D(W M-40X1#$P13X\.#A#.#,Q1C1#-#)",3DT,D(S03DV,#5&,37!E M+UA2968O5ULQ(#(@,5T^/G-T